| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,963 |
2,657 |
$281K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
172 |
80 |
$154K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
221 |
177 |
$22K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
135 |
121 |
$11K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
544 |
521 |
$9K |
| 96415 |
|
135 |
116 |
$4K |
| 99215 |
Prolong outpt/office vis |
39 |
29 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
20 |
14 |
$929.92 |